Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Electric Sensor Detects DNA for Disease Diagnosis

By LabMedica International staff writers
Posted on 01 Sep 2009
A newly developed electrical DNA biosensor will help to characterize pathogens and measure mRNA levels during expression profiling. More...
It will be suitable for point-of-care (POC) diagnosis and criminal investigations.

Scientists in Singapore developed the new electronic sensor that will offer a faster, less expensive, and more practical alternative to tests now used to detect DNA. The new lab-on-a-chip test will lead to wider, more convenient use of DNA testing.

Zhiqiang Gao, Ph.D., at the Institute of Bioengineering and Nanotechnology (IBN; Singapore) and colleagues developed a nanogap sensor. They used a pair of micro-sized metal electrodes separated by a nanogap, 1/50,000 the width of a human hair, in combination with special chemical probes to capture tiny segments of DNA. The newly formed circuit then translated the presence of DNA into an electrical signal that that was measured by a computer. In laboratory tests, the sensor showed excellent sensitivity at detecting trace amounts of human DNA.

Another feature of the biosensor was its ability to capture DNA strands more effectively. The two surfaces of the sensor were coated with a chemically treated capture probe solution through an electrochemical technique specially developed by IBN. This allowed DNA strands to stick more easily to the sensor, resulting in a faster and more accurate analysis.

Current methods for detecting DNA use the polymerase chain reaction (PCR), which amplifies trace amounts of DNA, making it easier to detect the genetic material. The amplification step is one of the reasons why PCR tests can be expensive, cumbersome, and imprecise. The newly developed biosensor should eliminate the need for DNA amplification altogether.

"This new biosensor holds significant promise to speed up on-going efforts in the detection and diagnosis of debilitating diseases such as cancer, cardiovascular problems, and infectious viruses. We aim to make healthcare accessible to the masses with early disease diagnosis as the critical driving force behind the research we undertake here at IBN," said Jackie Y. Ying, Ph.D., executive director of IBN.

The study was published in the September 2, 2009, issue of the Journal of the American Chemical Society.

Related Links:

Institute of Bioengineering and Nanotechnology



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.